Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Arava 20mg Film Coated Tablets - EU/1/99/118/007
- Aripiprazole Teva 10mg Tablets - PA1986/019/002
- Aripiprazole Teva 15mg Tablets - PA1986/019/003
- Atozet 10mg/80mg Film Coated Tablets - PA23198/022/004
- Benylin Dry Coughs Syrup - PA0330/018/001
- Benylin Dual Action Dry Syrup - PA0330/015/002
- Benylin Children’s Dry Coughs Syrup - PA0330/022/001
- Benylin Cough Medicine Syrup - PA0330/019/001
- Benylin Phlegm Cough plus Decongestant Syrup - PA0330/032/001
- Benylin Non-Drowsy Dry Coughs, Syrup - PA0330/025/001
- Calvepen 250mg/5ml Powder for Oral Suspension - PA0126/137/003
- Cardura XL 4mg Prolonged Release Tablets - PA23355/001/001
- Cardura XL 8mg Prolonged Release Tablets - PA23355/001/002
- Clavamel Forte 500mg/125mg Film Coated Tablet - PA0126/243/001
- Dermovate Scalp Application 0.05% w/v Cutaneous Solution - PA1077/005/003
- Drynol 20mg Tablets - PA0865/018/001
- Duac Once Daily 10mg/g + 50mg/g Gel - PA1077/120/001
- Eumovate Cream 0.05% w/w - PA1077/006/001
- Fydrane 0.2mg/ml + 3.1mg/ml + 10mg/ml Solution for Injection - PA1107/012/001
- Genotropin MiniQuick 0.2mg Powder and Solvent for Solution for Injection - PA0822/128/003
- Germentin 500mg/125mg Film Coated Tablets - PA0577/034/001
- Hydrea 500mg Hard Capsules - PA0002/027/001
- Klacid 250mg/5ml Granules for Oral Suspension - PA2010/004/006
- Lyrica 150mg Capsules - EU/1/04/279/018
- Mysimba 8mg/90mg Prolonged Release Tablets - EU/1/14/988/001
- Nicorette 15mg Inhaler - PA0330/037/010
- Nolpaza 40mg Gastro Resistant Tablets - PA1347/006/002
- Ozempic 0.25mg Solution for Injection - EU/1/17/1251/002
- Ozempic 0.5mg Solution for Injection - EU/1/17/1251/003
- Revatio 10mg/ml Powder for Oral Suspension- EU/1/05/318/003
- Sandostatin 500mcg/1ml, Solution for Injection/Infusion - PA0896/028/003
- Visudyne Powder for Solution for Infusion - EU/1/00/140/001
- Zithromax Powder for Oral Suspension 200mg/5ml - PA0822/191/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Abstral 100mcg Sublingual Tablets - PA2288/004/002
- Astilin 10mg Tablets - PA23163/001/001
- Ceftriaxone 1g Powder for Solution for Injection or Infusion - PA0281/225/001
- Cyklokapron 500mg Film Coated Tablets - PA2010/055/001
- Dioralyte Rebalance Blackcurrant Powder for Oral Solution - PA23180/023/001
- Exforge FCT 5mg/80mg - EU/1/06/370/003
- Lyrica 75mg Capsules - EU/1/04/279/012
- Nipent 10mg Powder for Solution for Injection - PA0822/228/001
- Oxynorm 5mg Hard Capsules - PA1688/006/004
- Rifadin 150mg Capsules - PA540/066/001
- Rocuronium 10 mg/ml Solution for Injection/Infusion - PA0736/029/001
- Sodium Iodide (I131) Capsule T - PA0690/006/002
- Solpadeine Soluble Tablets - PA1186/011/001
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.